タニ キミタカ   TANI Kimitaka
  谷 公孝
   所属   医学部 医学科(東京女子医科大学病院)
   職種   助教
Article types Original article
Language English
Peer review Peer reviewed
Title Differential prognostic impact of liver resection by the site of concurrent extrahepatic diseases in patients with colorectal cancer liver metastases: a nationwide multicenter study.
Journal Formal name:International journal of surgery
Abbreviation:Int J Surg
ISSN code:17439159/17439159
Domestic / ForeginForegin
Volume, Issue, Page 111(9),pp.5893-5903
Author and coauthor KATO Hirochika,SEISHIMA Ryo,OKUI Jun,SHIGETA Kohei,SATO Yasunori,KOBAYASHI Shin,SAKAMOTO Katsunori,KOBAYASHI Hirotoshi,KAWAI Kazushige,TANI KimitakaiAJIOKA, Yoichi,ENDO Itaru,TAKAHASHI Keiichi,OKABAYASHI Koji,KITAGAWA Yuko
Publication date 2025/09
Summary BACKGROUND:Liver resection for colorectal liver metastases (CRLM) with concurrent extrahepatic disease (EHD) has demonstrated potential benefits for long-term prognosis; however, its effectiveness remains controversial. Additionally, the prognostic impact of different EHD sites is not well elucidated. This study aimed to assess the significance of liver resection in patients with CRLM with concurrent EHD and evaluate how different EHD sites influence prognosis.METHODS:A nationwide multicenter database was used for a retrospective analysis of patients diagnosed during two periods: 2005-2007 and 2013-2015. EHD was classified into the following five subgroups: lung, peritoneum, lymph nodes, local, and others. The inverse probability of treatment weighting (IPTW) method was applied to minimize selection bias. Kaplan-Meier survival curves and Cox proportional hazards models were used to compare the overall survival (OS) between the different treatment groups and EHD subgroups.RESULTS:Among 3787 patients, 874 (23.1%) underwent liver resection. Following IPTW adjustment, the hepatectomy (HT) group demonstrated significantly better OS than the non-hepatectomy (non-HT) group (5-year hazard ratio, 0.322; 95% confidence interval, 0.273-0.379; P < 0.001). Analysis by the EHD site subgroup demonstrated that liver resection was associated with a better prognosis across all sites. However, the prognostic impact differed by EHD site, with peritoneal metastasis associated with poorer outcomes in both the HT (5-year OS rates, 30.1% vs. 45.0%) and non-HT (5-year OS rates, 4.4% vs. 8.6%) groups.CONCLUSIONS:Regardless of the EHD site, liver resection was associated with a significantly better OS in patients with CRLM with concurrent EHD. The prognostic impact varies across EHD sites, underscoring the significance of considering differential prognostic risks when selecting treatment strategies.
DOI 10.1097/JS9.0000000000002727
PMID 40511963